Alessandro Di Federico; Kaiwen Wang; Monica F Chen; Adam A Barsouk; Arianna Pagliaro; Lanyi N Chen; Francesca R Ogliari; Paul Stockhammer; Rajat Thawani; Shahm Raslan; Eleonora Gariazzo; Francesca Fusco; Grace M Hambelton; Fabrizio Citarella; David Meyer; Mihaela Aldea; Andrea De Giglio; Joao V Alessi; Federica Pecci; Francesco Gelsomino; Marcelo Corassa; Natalie I Vokes; Xinan Wang; Dario de Biase; Fawzi Abu Rous; Phurin Areesawangkit; Omar Elghawy; Alessio Cortellini; Giulio Metro; Roberto Ferrara; Mark M Awad; Aliyah Pabani; Joseph C Murray; Federico Cappuzzo; Marina C Garassino; Ibiayi Dagogo-Jack; Gregory Riely; Michael Grant; Benjamin O Herzberg; Andrea Ardizzoni; David Planchard; Bruce E Johnson; Corey J Langer; Michael Offin; Marcelo V Negrao; Biagio Ricciuti

Lung adenocarcinomas with mucinous histology: clinical, genomic, and immune microenvironment characterization and outcomes to immunotherapy-based treatments and KRASG12C inhibitors

黏液性组织学特征的肺腺癌：临床、基因组学和免疫微环境特征及对基于免疫疗法治疗和KRASG12C抑制剂的疗效

ANNALS OF ONCOLOGY

IF65.4

2025-03-014

PRE

Di Federico, A.; Hong, L.; Elkrief, A.; Thummalapalli, R.; Cooper, A. J.; Ricciuti, B.; Digumarthy, S.; Alessi, J. V.; Gogia, P.; Pecci, F.; Makarem, M.; Gandhi, M. M.; Garbo, E.; Saini, A.; De Giglio, A.; Favorito, V.; Scalera, S.; Cipriani, L.; Marinelli, D.; Haradon, D.; Nguyen, T.; Haradon, J.; Voligny, E.; Vaz, V.; Gelsomino, F.; Sperandi, F.; Melotti, B.; Ladanyi, M.; Zhang, J.; Gibbons, D. L.; Heymach, J. V.; Nishino, M.; Lindsay, J.; Rodig, S. J.; Pfaff, K.; Sholl, L. M.; Wang, X.; Johnson, B. E.; Janne, P. A.; Rekhtman, N.; Maugeri-Sacca, M.; Heist, R. S.; Ardizzoni, A.; Awad, M. M.; Arbour, K. C.; Schoenfeld, A. J.; Vokes, N. I.; Luo, J.

PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD)

JOURNAL OF TRANSLATIONAL MEDICINE

IF7.5

2025-01-020

OAAI

Angelicola, Stefania; Giunchi, Francesca; Ruzzi, Francesca; Frascino, Mariateresa; Pitzalis, Mary; Scalambra, Laura; Semprini, Maria Sofia; Pittino, Olga Maria; Cappello, Chiara; Siracusa, Irene; Chillico, Ilaria Candida; Di Noia, Martina; Turato, Cristian; De Siervi, Silvia; Lescai, Francesco; Ciavattini, Teresa; Lopatriello, Giulia; Bertoli, Luca; De Jonge, Hugo; Iamele, Luisa; Altimari, Annalisa; Gruppioni, Elisa; Ardizzoni, Andrea; Rossato, Marzia; Gelsomino, Francesco; Lollini, Pier-Luigi; Palladini, Arianna

Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary

MOLECULAR THERAPY

IF12

2024-10-011

OAAI

Cavazzoni, Andrea; Salamon, Irene; Fumarola, Claudia; Gallerani, Giulia; Laprovitera, Noemi; Gelsomino, Francesco; Riefolo, Mattia; Rihawi, Karim; Porcellini, Elisa; Rossi, Tania; Mazzeschi, Martina; Naddeo, Maria; Serravalle, Salvatore; Broseghini, Elisabetta; Agostinis, Federico; Deas, Olivier; Roncarati, Roberta; Durante, Giorgio; Pace, Ilaria; Lauriola, Mattia; Garajova, Ingrid; Calin, George A.; Bonafe, Massimiliano; D'Errico, Antonia; Petronini, Pier Giorgio; Cairo, Stefano; Ardizzoni, Andrea; Sales, Gabriele; Ferracin, Manuela

An Italian multicenter phase II trial of metronomic temozolomide in unfit patients with advanced neuroendocrine neoplasms: Interim analysis of the MeTe study

一项关于米兰多中心II期试验中，在不符合条件的晚期神经内分泌肿瘤患者中应用节律性替莫唑胺的意大利研究：MeTe研究的期中分析

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Pattern of expression, transcriptional states and clinical implications of tumour-infiltrating lymphocytes (TILs) in curatively-treated cholangiocarcinoma (CCA) patients (pts): The TILBIL study

表达模式、转录状态及肿瘤浸润淋巴细胞（TILs）在治愈性治疗的胆管癌（CCA）患者（pts）中的临床意义：TILBIL研究

ANNALS OF ONCOLOGY

IF65.4

2024-09-010

PRE

Pattern of expression, transcriptional states and clinical implications of tumour-infiltrating lymphocytes (TILs) in curatively-treated cholangiocarcinoma (CCA) patients (pts): The TILBIL study

ANNALS OF ONCOLOGY

IF65.4

2024-06-010

PRE

Activity of osimeRTInib in non-small-cell lung Cancer with UNcommon epidermal growth factor receptor mutations: retrospective Observational multicenter study (ARTICUNO)

奥希替尼在具有罕见表皮生长因子受体突变的非小细胞肺癌中的活性: 回顾性观察性多中心研究 (ARTICUNO)

ESMO OPEN

IF8.3

2024-06-011

OAAI

Pizzutilo, E. G.; Agostara, A. G.; Oresti, S.; Signorelli, D.; Stabile, S.; Lauricella, C.; Motta, V.; Amatu, A.; Ruggieri, L.; Brambilla, M.; Occhipinti, M.; Proto, C.; Giusti, R.; Filetti, M.; Genova, C.; Barletta, G.; Gelsomino, F.; Bennati, C.; Siringo, M.; Di Fazio, G. R.; Russano, M.; Montrone, M.; Gariazzo, E.; Roca, E.; Bordi, P.; Delmonte, A.; Scimone, A.; Belluomini, L.; Mazzoni, F.; Carta, A.; Pelizzari, G.; Viscardi, G.; Morgillo, F.; Gelibter, A.; Gori, S.; Berardi, R.; Cortinovis, D.; Ardizzoni, A.; Veronese, S. M.; Sartore-Bianchi, A.; Giannetta, L. G.; Cerea, G.; Siena, S.

Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed

EUROPEAN JOURNAL OF CANCER

IF7.1

2024-05-013

PRE

Leonetti, Alessandro; Perrone, Fabiana; Puntoni, Matteo; Maglietta, Giuseppe; Bordi, Paola; Bria, Emilio; Vita, Emanuele; Gelsomino, Francesco; De Giglio, Andrea; Gelibter, Alain; Siringo, Marco; Mazzoni, Francesca; Caliman, Enrico; Genova, Carlo; Bertolini, Federica; Guaitoli, Giorgia; Passiglia, Francesco; Delcuratolo, Marco Donatello; Montrone, Michele; Cerea, Giulio; Pasello, Giulia; Roca, Elisa; Belluomini, Lorenzo; Cecere, Fabiana Letizia; Guida, Annalisa; Manzo, Anna; Adamo, Vincenzo; Rastelli, Francesca; Bulotta, Alessandra; Citarella, Fabrizio; Toschi, Luca; Zoratto, Federica; Cortinovis, Diego Luigi; Berardi, Rossana; Follador, Alessandro; Carta, Annamaria; Camerini, Andrea; Salerno, Flavio; Silva, Rosa Rita; Baldini, Editta; Cortellini, Alessio; Brighenti, Matteo; Santoni, Matteo; Malorgio, Francesco; Caminiti, Caterina; Tiseo, Marcello

A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small cell lung cancer

FUTURE ONCOLOGY

IF2.6

2024-02-150

OAAI

From Development to Place in Therapy of Lorlatinib for the Treatment of ALK and ROS1 Rearranged Non-Small Cell Lung Cancer (NSCLC)

DIAGNOSTICS

IF3.3

2023-12-254

OAAI

STK11 mutations predict poor prognosis for advanced NSCLC treated with first-line immunotherapy or chemoimmunotherapy according to KRAS, TP53, KEAP1, and SMARCA4 status

ANNALS OF ONCOLOGY